Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124933323 | 12493332 | 3 | F | 20150928 | 20160727 | 20160623 | 20160810 | EXP | GB-PFIZER INC-2015327549 | PFIZER | 77.00 | YR | M | Y | 78.00000 | KG | 20160810 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124933323 | 12493332 | 1 | SS | INOTUZUMAB OZOGAMICIN | INOTUZUMAB OZOGAMICIN | 1 | Intravenous (not otherwise specified) | 0.96 MG/ML SINGLE | 0 | ||||||||||
| 124933323 | 12493332 | 2 | PS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | Intravenous (not otherwise specified) | 2 MG, SINGLE | U | 71484 | 2 | MG | |||||||
| 124933323 | 12493332 | 3 | SS | RITUXIMAB | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 720 MG, SINGLE | U | 0 | 720 | MG | |||||||
| 124933323 | 12493332 | 4 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 100 MG, 1X/DAY | 3300 | MG | U | 0 | 100 | MG | QD | ||||
| 124933323 | 12493332 | 5 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 1400 MG, SINGLE | U | 0 | 1400 | MG | |||||||
| 124933323 | 12493332 | 6 | C | CHLORPHENAMINE | CHLORPHENIRAMINE MALEATE | 1 | Intravenous (not otherwise specified) | 10 MG, SINGLE | 0 | 10 | MG | ||||||||
| 124933323 | 12493332 | 7 | C | ONDANSETRON | ONDANSETRON | 1 | Oral | 8 MG, SINGLE | 0 | 8 | MG | ||||||||
| 124933323 | 12493332 | 8 | C | FILGRASTINE | 2 | Subcutaneous | 300 MG, 1X/DAY | 0 | 300 | MG | QD | ||||||||
| 124933323 | 12493332 | 9 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Oral | 10 - 20 MG, AS NEEDED | 0 | ||||||||||
| 124933323 | 12493332 | 10 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 300 MG, DAILY | 0 | 300 | MG | ||||||||
| 124933323 | 12493332 | 11 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | Oral | 50 MG, DAILY | 0 | 50 | MG | ||||||||
| 124933323 | 12493332 | 12 | C | DIGOXIN. | DIGOXIN | 1 | Oral | 125 ?G, 1X/DAY | 0 | 125 | UG | QD | |||||||
| 124933323 | 12493332 | 13 | C | ASPIRIN (E.C.) | ASPIRIN | 1 | Oral | 75 MG, 1X/DAY | 0 | 75 | MG | QD | |||||||
| 124933323 | 12493332 | 14 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | QD | |||||||
| 124933323 | 12493332 | 15 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | QD | |||||||
| 124933323 | 12493332 | 16 | C | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | Oral | 200 MG, 2X/DAY | 0 | 200 | MG | BID | |||||||
| 124933323 | 12493332 | 17 | C | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Oral | 20 MG, 1X/DAY | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124933323 | 12493332 | 1 | Diffuse large B-cell lymphoma |
| 124933323 | 12493332 | 2 | Diffuse large B-cell lymphoma |
| 124933323 | 12493332 | 3 | Diffuse large B-cell lymphoma |
| 124933323 | 12493332 | 4 | Diffuse large B-cell lymphoma |
| 124933323 | 12493332 | 5 | Diffuse large B-cell lymphoma |
| 124933323 | 12493332 | 6 | Prophylaxis |
| 124933323 | 12493332 | 7 | Prophylaxis of nausea and vomiting |
| 124933323 | 12493332 | 8 | Prophylaxis |
| 124933323 | 12493332 | 9 | Prophylaxis of nausea and vomiting |
| 124933323 | 12493332 | 10 | Prophylaxis |
| 124933323 | 12493332 | 11 | Prophylaxis |
| 124933323 | 12493332 | 13 | Aortic valve replacement |
| 124933323 | 12493332 | 14 | Fluid overload |
| 124933323 | 12493332 | 15 | Gastrointestinal haemorrhage |
| 124933323 | 12493332 | 16 | Rheumatoid arthritis |
| 124933323 | 12493332 | 17 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124933323 | 12493332 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124933323 | 12493332 | Infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124933323 | 12493332 | 1 | 20150821 | 20150918 | 0 | |
| 124933323 | 12493332 | 2 | 20150820 | 20150917 | 0 | |
| 124933323 | 12493332 | 3 | 20150820 | 20150917 | 0 | |
| 124933323 | 12493332 | 4 | 20150820 | 20150921 | 0 | |
| 124933323 | 12493332 | 5 | 20150820 | 20150917 | 0 | |
| 124933323 | 12493332 | 6 | 20150820 | 20150917 | 0 | |
| 124933323 | 12493332 | 7 | 20150820 | 20150917 | 0 | |
| 124933323 | 12493332 | 8 | 20150823 | 20150928 | 0 | |
| 124933323 | 12493332 | 9 | 20150820 | 0 | ||
| 124933323 | 12493332 | 10 | 20150815 | 20150927 | 0 | |
| 124933323 | 12493332 | 11 | 20150815 | 20150928 | 0 | |
| 124933323 | 12493332 | 12 | 20150928 | 0 | ||
| 124933323 | 12493332 | 13 | 20150928 | 0 | ||
| 124933323 | 12493332 | 14 | 20150927 | 20150929 | 0 | |
| 124933323 | 12493332 | 15 | 20150928 | 0 | ||
| 124933323 | 12493332 | 16 | 20150928 | 0 | ||
| 124933323 | 12493332 | 17 | 201107 | 20150928 | 0 |